Sarel Chaim Chen Tov

Sarel Chaim Chen Tov

Active Director Director DIN 02205437
DIN 02205437 First appointment Jun 2008 Primary industry Engineering
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2008
Shareholding value •••• Premium profile

About Sarel Chaim Chen Tov

Data last updated:

Sarel Chaim Chen Tov is a Director at Biopharmax India Private Limited (since 2008). The company operates in Engineering. Biopharmax India Private Limited reported revenue of ₹16.04 Cr (FY 2025).

DIN 02205437
Primary Designation Director
Industry Engineering
First Appointment 30 Jun 2008
Oldest Company Age 20 yrs
Largest company Biopharmax India Private Limited · ₹16.04 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biopharmax India Private Limited U45201PN2006FTC138676
Director30 Jun 20082006₹16.04 Cr (FY 2025)Active

Board colleagues of Sarel Chaim Chen Tov

Directorship timeline

Open interactive timeline →
Biopharmax India Private Limited
Premium access

Shareholding and investment profile for Sarel Chaim Chen Tov

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarel Chaim Chen Tov

Sarel Chaim Chen Tov currently holds 1 directorship: Biopharmax India Private Limited (Director, since 30 Jun 2008, revenue ₹16.04 Cr (FY 2025)).

Sarel Chaim Chen Tov was first appointed on 30 Jun 2008 as Director at Biopharmax India Private Limited.

The current boards of Sarel Chaim Chen Tov's companies include Atul Anil Pabalkar (Biopharmax India Private Limited), Sandhya Bindumadhav Deshpande (Biopharmax India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available